Artificial neural network in breast lesions from fine-needle aspiration cytology smear

Artificial neural networks (ANNs) are applied in engineering and certain medical fields. ANN has immense potential and is rarely been used in breast lesions. In this present study, we attempted to build up a complete robust back propagation ANN model based on cytomorphological data, morphometric dat...

Full description

Saved in:
Bibliographic Details
Published inDiagnostic cytopathology Vol. 42; no. 3; pp. 218 - 224
Main Authors Subbaiah, R. M., Dey, Pranab, Nijhawan, Raje
Format Journal Article
LanguageEnglish
Published United States Blackwell Publishing Ltd 01.03.2014
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Artificial neural networks (ANNs) are applied in engineering and certain medical fields. ANN has immense potential and is rarely been used in breast lesions. In this present study, we attempted to build up a complete robust back propagation ANN model based on cytomorphological data, morphometric data, nuclear densitometric data, and gray level co‐occurrence matrix (GLCM) of ductal carcinoma and fibroadenomas of breast cases diagnosed on fine‐needle aspiration cytology (FNAC). We selected 52 cases of fibroadenomas and 60 cases of infiltrating ductal carcinoma of breast diagnosed on FNAC by two cytologists. Essential cytological data was quantitated by two independent cytologists (SRM, PD). With the help of Image J software, nuclear morphomeric, densitometric, and GLCM features were measured in all the cases on hematoxylin and eosin‐stained smears. With the available data, an ANN model was built up with the help of Neurointelligence software. The network was designed as 41‐20‐1 (41 input nodes, 20 hidden nodes, 1 output node). The network was trained by the online back propagation algorithm and 500 iterations were done. Learning was adjusted after every iteration. ANN model correctly identified all cases of fibroadenomas and infiltrating carcinomas in the test set. This is one of the first successful composite ANN models of breast carcinomas. This basic model can be used to diagnose the gray zone area of the breast lesions on FNAC. We assume that this model may have far‐reaching implications in future. Diagn. Cytopathol. 2014;42:218–224. © 2013 Wiley Periodicals, Inc.
Bibliography:istex:FCD2A2FE1A59378552FDE82C2AE2BAFEBDECEED4
ArticleID:DC23026
ark:/67375/WNG-1H2WDV19-0
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:8755-1039
1097-0339
DOI:10.1002/dc.23026